Literature DB >> 16275949

Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.

M S Buckland1, M Mylonaki, D Rampton, H J Longhurst.   

Abstract

We have evaluated the utility of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies for distinguishing Crohn's disease from ulcerative colitis and other diarrheal illnesses by evaluating sera from 396 patients. Sensitivity, specificity, and phenotypic correlations were investigated. The implications of our findings for implementing these tests in routine clinical testing are discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16275949      PMCID： PMC1287772          DOI： 10.1128/CDLI.12.11.1328-1330.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  11 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 2.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

4.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Authors:  J Halfvarson; A Standaert-Vitse; G Järnerot; B Sendid; T Jouault; L Bodin; A Duhamel; J F Colombel; C Tysk; D Poulain
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

5.  Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.

Authors:  Carmen Monica Preda; Mircea Diculescu; Virginia Mirea; Catalin Marica; Severine Vermeire; Paul Rutgeerts; Alexandru Oproiu
Journal:  Rom J Gastroenterol       Date:  2005-03

6.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.

Authors:  J F Quinton; B Sendid; D Reumaux; P Duthilleul; A Cortot; B Grandbastien; G Charrier; S R Targan; J F Colombel; D Poulain
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.

Authors:  A Montanelli; E Mainardi; A Vagni; V Villanacci; C Zambelli; R Cestari; P Cengia; L Minelli; G Missale
Journal:  Minerva Gastroenterol Dietol       Date:  2005-06

8.  Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.

Authors:  J Bartůnková; I Kolárová; A Sedivá; E Hölzelová
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

9.  Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value.

Authors:  Takashi Hisabe; Toshiyuki Matsui; Toshihiro Sakurai; Yuji Murakami; Hiroshi Tanabe; Hiroaki Matake; Tsuneyoshi Yao; Shino Kamachi; Akinori Iwashita
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

10.  The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study.

Authors:  M Boirivant; M Leoni; D Tariciotti; S Fais; O Squarcia; F Pallone
Journal:  J Clin Gastroenterol       Date:  1988-08       Impact factor: 3.062
View more
  3 in total

1.  Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.

Authors:  Renato Mitsunori Nisihara; Wilson Beleski de Carvalho; Shirley Ramos da Rosa Utiyama; Heda Amarante; Márcia Luiza Baptista
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

2.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

3.  Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis.

Authors:  Yanhua Pang; Huijie Ruan; Dongfang Wu; Yanfei Lang; Ke Sun; Cuiping Xu
Journal:  Allergy Asthma Clin Immunol       Date:  2020-05-20       Impact factor: 3.406
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.